Back

AHRE and subclinical atrial fibrillation: when to start oral anticoagulation

25 April 2021 (12:08 - 12:19)
Organised by:
Congress Presentation Part of: 2020 ESC Guidelines on Atrial Fibrillation, focus on oral anticoagulation Oral Anticoagulation EHRA Premium Access EHRA 2021

About the speaker

Photo
Professor Paulus Kirchhof

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

4 More presentations in this session

Presentation thumbnail
Oral anticoagulant and acute coronary syndrome
Doctor J. Moses (Cape Town, ZA)
Slides Video
Presentation thumbnail
Periprocedural oral anticoagulant management in rhythm control interventions
Professor T. Potpara (Belgrade, RS)
Slides Video
Presentation thumbnail
Oral anticoagulant and bleeding: role of antidotes
Doctor K. Govender (Johannesburg, ZA)
Slides Video
Presentation thumbnail
2020 ESC Guidelines on Atrial Fibrillation, focus on oral anticoagulation - discussion
Video

Access the full session

Session thumbnail
2020 ESC Guidelines on Atrial Fibrillation, focus on oral anticoagulation

The Event

Event poster

EHRA 2021

25 April 2021 12:08 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources